GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Zenlabs Ethica Ltd (BOM:530697) » Definitions » Return-on-Tangible-Equity

Zenlabs Ethica (BOM:530697) Return-on-Tangible-Equity : 3.32% (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Zenlabs Ethica Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Zenlabs Ethica's annualized net income for the quarter that ended in Dec. 2024 was ₹3.4 Mil. Zenlabs Ethica's average shareholder tangible equity for the quarter that ended in Dec. 2024 was ₹102.6 Mil. Therefore, Zenlabs Ethica's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 was 3.32%.

The historical rank and industry rank for Zenlabs Ethica's Return-on-Tangible-Equity or its related term are showing as below:

BOM:530697' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -9.34   Med: 6.94   Max: 18.18
Current: 3.29

During the past 13 years, Zenlabs Ethica's highest Return-on-Tangible-Equity was 18.18%. The lowest was -9.34%. And the median was 6.94%.

BOM:530697's Return-on-Tangible-Equity is ranked worse than
72.22% of 108 companies
in the Medical Distribution industry
Industry Median: 8.555 vs BOM:530697: 3.29

Zenlabs Ethica Return-on-Tangible-Equity Historical Data

The historical data trend for Zenlabs Ethica's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenlabs Ethica Return-on-Tangible-Equity Chart

Zenlabs Ethica Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.34 9.61 8.74 5.14 4.25

Zenlabs Ethica Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.63 6.03 1.65 2.01 3.32

Competitive Comparison of Zenlabs Ethica's Return-on-Tangible-Equity

For the Medical Distribution subindustry, Zenlabs Ethica's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenlabs Ethica's Return-on-Tangible-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Zenlabs Ethica's Return-on-Tangible-Equity falls into.


;
;

Zenlabs Ethica Return-on-Tangible-Equity Calculation

Zenlabs Ethica's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=4.212/( (97.035+101.23 )/ 2 )
=4.212/99.1325
=4.25 %

Zenlabs Ethica's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Sep. 2024 )(Q: Dec. 2024 )
=3.404/( (102.634+0)/ 1 )
=3.404/102.634
=3.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Zenlabs Ethica  (BOM:530697) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Zenlabs Ethica Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Zenlabs Ethica's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenlabs Ethica Business Description

Traded in Other Exchanges
N/A
Address
Plot No.194-195, 3rd Floor, Industrial Area, Phase-II, Ram Darbar, Chandigarh, IND, 160002
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.

Zenlabs Ethica Headlines

No Headlines